2 min read

EverHint – EMA 10/30 Crossover, SMA 20/50 Crossover, EMA 10 + Price + MACD – Top 6 Buy and Top 10 Sell Signals for Nov 17, 2026

16 signals (from 64 total). Healthcare leads (15). price range $10-$396. 3 with insider selling.

Excerpt: 16 signals (from 64 total). Healthcare leads (15). price range $10-$396. 3 with insider selling.

EMA 10/30 Crossover

Detects fresh crossovers between the 10-day exponential moving average (EMA10) and the 30-day exponential moving average (EMA30), generating both buy and sell signals. Uses two EMAs instead of EMA + SMA, making it more responsive to price changes and better suited for capturing short-to-medium term momentum shifts.

Entry Criteria:

  • Buy: EMA10 crosses above EMA30
  • Sell: EMA10 crosses below EMA30
  • Minimum ADV: $40M (liquidity filter)
  • Earnings buffer: 7 days pre/post earnings
  • Fresh crossover: Detected on today's close

Holding period: 1-4 weeks | Risk level: Medium

🟢 Buy Signals (4 of 4)

Ranked by RSI (lower RSI for buy signals = more oversold)

# Ticker Company Sector Price Insider MCap
1 CAKE The Cheesecake Factory... Consumer Cyclical $111.96 — $5.6B
2 RARE Ultragenyx Pharmaceuti... Healthcare $16.70 — $1.7B
3 TRGP Targa Resources Corp. Energy $291.35 — $62.5B
4 ZIM ZIM Integrated Shippin... Industrials $29.69 — $3.6B

🔴 Sell Signals (5 of 53)

# Ticker Company Sector Price Insider MCap
1 AAMI Acadian Asset Management Financial Services $86.97 — $3.1B
2 AI C3.ai, Inc. Technology $9.96 — $1.5B
3 ANF Abercrombie & Fitch Co. Consumer Cyclical $142.85 — $6.1B
4 AR Antero Resources Corpo... Energy $36.83 — $11.3B
5 AX Axos Financial, Inc. Financial Services $88.15 — $5.0B

SMA 20/50 Crossover

Detects fresh crossovers between the 20-day simple moving average (SMA20) and the 50-day simple moving average (SMA50). Uses two SMAs, making it more stable and less prone to false signals compared to EMA-based strategies. Well-suited for identifying medium-term trend changes with higher reliability.

Entry Criteria:

  • Buy: SMA20 crosses above SMA50
  • Sell: SMA20 crosses below SMA50
  • Minimum ADV: $40M (liquidity filter)
  • Earnings buffer: 7 days pre/post earnings
  • Fresh crossover: Detected on today's close

Holding period: 2-6 weeks | Risk level: Medium

🟢 Buy Signals (1 of 1)

Ranked by RSI (lower RSI = more oversold for buy signals)

# Ticker Company Sector Price Insider MCap
1 STNG Scorpio Tankers Inc. Industrials $80.69 — $4.1B

🔴 Sell Signals (5 of 5)

# Ticker Company Sector Price Insider MCap
1 CAI Caris Life Sciences, Inc. Healthcare $19.94 — $5.7B
2 MPC Marathon Petroleum Cor... Energy $395.61 — $107.7B
3 MTCH Match Group, Inc. Communication Services $40.09 — $9.1B
4 OSCR Oscar Health, Inc. Healthcare $29.84 — $7.7B
5 PSX Phillips 66 Energy $256.93 — $100.2B

EMA 10 + Price + MACD

Experimental strategy combining price crossing above EMA10 from below with MACD Line crossing above Signal Line from below. Both conditions must occur on the same day for a signal, providing double confirmation and higher-quality setups.

Entry Criteria:

  • Buy: Price > EMA10 AND MACD line crosses above signal line
  • Sell: Price < EMA10 AND MACD line crosses below signal line
  • Minimum ADV: $40M (liquidity filter)
  • Earnings buffer: 7 days pre/post earnings
  • Fresh signal: All conditions met on today's close

Holding period: 1-3 weeks | Risk level: Medium-High

🟢 Buy Signals (1 of 1)

Ranked by RSI (lower RSI = more oversold for buy signals)

# Ticker Company Sector Price Insider MCap
1 SLS SELLAS Life Sciences G... Healthcare $19.15 — $3.9B

Recent Headlines

SLS (SELLAS Life Sciences Group, Inc.)

  • SELLAS Life Sciences Group, Inc. (SLS) Discusses Positive Phase III REGAL Trial Results for Galinpepimut-S in Acute Myeloid Leukemia Prepared Remarks Transcript
  • SELLAS Life Sciences Announces Proposed $150.0 Million Underwritten Public Offering

Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/

📢 Support the project by liking, sharing, or subscribing — it helps more readers discover these signals.